Elanco Animal Health 

€21.2
51
+€0+0% Thursday 13:48

統計

當日最高
21.2
當日最低
21.2
52週高點
-
52週低點
-
成交量
80
平均成交量
-
市值
10.53B
本益比
-
股息殖利率
-
股息
-

即將到來

財報

24Feb預期
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
下一步
0.11
0.2
0.28
0.37
預期EPS
0.11346
實際EPS
不適用

財務

7.47%利潤率
有盈利
2019
2020
2021
2022
2023
2024
8.42B營收
628.58M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 5EA.XETRA 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Show more...
執行長
Mr. Jeffrey N. Simmons
員工
9000
國家
US
ISIN
US28414H1032
WKN
000A2N6BH

上市

0 Comments

分享你的想法

FAQ

Elanco Animal Health 今天的股價是多少?
5EA.XETRA 目前價格為 €21.2 EUR,過去 24 小時上漲了 +0%。在圖表上更密切關注 Elanco Animal Health 股價表現。
Elanco Animal Health 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Elanco Animal Health 的股票以代號 5EA.XETRA 進行交易。
Elanco Animal Health 的市值是多少?
今天 Elanco Animal Health 的市值為 10.53B
Elanco Animal Health 下一次財報日期是什麼時候?
Elanco Animal Health 將於 February 24, 2026 公布下一次財報。
Elanco Animal Health 上一季度的財報如何?
5EA.XETRA 上一季度的財報為每股 0.17 EUR,預估為 0.11 EUR,帶來 +46.16% 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Elanco Animal Health 去年的營收是多少?
Elanco Animal Health 去年的營收為 8.42BEUR。
Elanco Animal Health 去年的淨利是多少?
5EA.XETRA 去年的淨收益為 628.58MEUR。
Elanco Animal Health 有多少名員工?
截至 February 06, 2026,公司共有 9,000 名員工。
Elanco Animal Health 位於哪個產業?
Elanco Animal Health從事於Health Care產業。
Elanco Animal Health 何時完成拆股?
Elanco Animal Health 最近沒有進行任何拆股。
Elanco Animal Health 的總部在哪裡?
Elanco Animal Health 的總部位於 US 的 Greenfield。